Too-"l-pharma", Sofosbuvir Import Data from India (DGFT 2022–2026)

Q: Who are the top buyers of Sofosbuvir from India and how much does Too-"l-pharma", import?

India exports Sofosbuvir to 377 buyers globally worth $2.1M. Too-"l-pharma", imports $200.0K (0.5% market share) with 4 shipments from KAZAKHSTAN.

Q: What is the average order value for Too-"l-pharma",'s Sofosbuvir imports?

Too-"l-pharma",'s average Sofosbuvir order value is $50.0K per consignment, based on 4 shipments totaling $200.0K.

Q: Who supplies Sofosbuvir to Too-"l-pharma",?

Top Indian Sofosbuvir suppliers: MYLAN LABORATORIES LIMITED ($9.9M), HETERO LABS LIMITED ($5.3M), NATCO PHARMA LIMITED ($800.0K), HEET HEALTHCARE PRIVATE LIMITED ($370.8K), EURO LIFECARE PRIVATE LIMITED ($350.0K).

Q: How does Too-"l-pharma", compare to other Sofosbuvir importers?

Too-"l-pharma", ranks #11 among 377 Sofosbuvir importers from India with 0.5% market share and 4 shipments.

Q: Who are the top Sofosbuvir importers from India?

Top Sofosbuvir importers: UNDP OFFICE IN TURKMENISTAN ($500.0K), ETHIOPIAN PHARMACEUTICALS SUPPLY AGENCY EPSA ADDIS ABABAP O ($300.0K), TOO-"L-PHARMA", ($200.0K), UNOPS MYANMAR OC ($200.0K), SIA "MAGNIPHARMA", ($150.0K).

Suresh Sormare

Sofosbuvir

India Pharmaceutical Trade Intelligence

$40.9M150 Suppliers113 CountriesHS 30049099

ExportsIndia → VIETNAM12.4%India → ETHIOPIA9.2%

ImportsUNITED STATES → India$206.1K GERMANY → India$43.1K

#1 Supplier: MYLAN LABORATORIES

Too-"l-pharma", — Sofosbuvir Importer #11 | $200.0K Trade Value | TransData Nexus | TransData Nexus

Too-"l-pharma", — Sofosbuvir Importer Profile

Pharmaceutical Importer · #11 buyer for Sofosbuvir · $200.0K import value · 4 shipments · KAZAKHSTAN · DGFT Verified

Too-"l-pharma", is the #11 importer of Sofosbuvir from India with $200.0K in import value and 4 verified shipments. Too-"l-pharma", holds a 0.5% market share in Sofosbuvir imports based in KAZAKHSTAN.

Too-"l-pharma", — Sofosbuvir Import Profile: Suppliers, Formulations & Sources

Too-"l-pharma", — Sofosbuvir import analysis from Indian Customs (DGFT) data.

Who Supplies Sofosbuvir to Too-"l-pharma",?

Supplier	Value	Shipments	% Share
MYLAN LABORATORIES LIMITED	$9.9M	199	44
HETERO LABS LIMITED	$5.3M	105	18
NATCO PHARMA LIMITED	$800.0K	16	7
HEET HEALTHCARE PRIVATE LIMITED	$370.8K

How Does Too-"l-pharma", Compare to Nearest Sofosbuvir Importers?

Buyers ranked immediately above and below #11 by import value

#	Buyer	Country	Import Value	Shipments	Avg/Shipment
8	UNDP OFFICE IN TURKMENISTAN	TURKMENISTAN	$500.0K	10	$50.0K
1	ETHIOPIAN PHARMACEUTICALS SUPPLY AGENCY EPSA ADDIS ABABAP O	ETHIOPIA	$300.0K	6	$50.0K
11	TOO-"L-PHARMA", ★	KAZAKHSTAN	$200.0K	4	$50.0K
12	UNOPS MYANMAR OC	MYANMAR	$200.0K	4	$50.0K
2	SIA "MAGNIPHARMA",	LATVIA	$150.0K	3	$50.0K

Too-"l-pharma", ranks #11 among 377 Sofosbuvir importers from India. Average shipment value of $50.0K compared to the market average of $5.7K. The closest competitors by value are UNDP OFFICE IN TURKMENISTAN and ETHIOPIAN PHARMACEUTICALS SUPPLY AGENCY EPSA ADDIS ABABAP O.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Sofosbuvir shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
2.Buyer Identification: Too-"l-pharma", matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
4.Market Share: Calculated as Too-"l-pharma",'s capped import value divided by total capped export value for Sofosbuvir across all Indian exporters.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 113+ countries, 377+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Sofosbuvir

Sofosbuvir

Too-"l-pharma", — Sofosbuvir Importer Profile

Too-"l-pharma", — Sofosbuvir Import Profile: Suppliers, Formulations & Sources

Who Supplies Sofosbuvir to Too-"l-pharma",?

How Does Too-"l-pharma", Compare to Nearest Sofosbuvir Importers?

Who Are the Top Buyers of Sofosbuvir from India and How Much Does Too-"l-pharma", Import?

What Is the Average Order Value for Too-"l-pharma",'s Sofosbuvir Imports?

Who Supplies Sofosbuvir to Too-"l-pharma",?

How Does Too-"l-pharma", Compare to Other Sofosbuvir Importers?

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Sofosbuvir Import Data for Too-"l-pharma",

Too-"l-pharma", × Sofosbuvir

Related Analysis

Need Detailed Import Data?

Data Source